P1009: SKLB054, A NOVEL JAK2 INHIBITOR, POTENTLY TREATS MYELOPROLIFERATIVE NEOPLASM WITH JAK2V617F MUTATION
Ailin Zhao,
Tao Yang,
Linyu Yang,
Mengshi Hu,
Xin Wang,
Jinjin Wang,
Meng LI,
LI Wang,
Jinbing Zhu,
Lijuan Chen,
Ting Niu
Affiliations
Ailin Zhao
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
Tao Yang
2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China
Linyu Yang
2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China
Mengshi Hu
2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China
Xin Wang
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
Jinjin Wang
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
Meng LI
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
LI Wang
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
Jinbing Zhu
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
Lijuan Chen
2 West China Hospital, Sichuan University, State Key Laboratory of Biotherapy and Cancer Center, National Clinical Research Center for Geriatrics, Chengdu, China
Ting Niu
1 West China Hospital, Sichuan University, Department of Hematology, Chengdu, China
